Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
EGFR mutation test
GENETIC
2 trials
Sponsors
AstraZeneca
Conditions
EGFR Mutation Status in aNSCLC Patients
Non-small Cell Lung Cancer
Phase 4
A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa
Completed
NCT01000740
AstraZeneca
Non-small Cell Lung Cancer
Start: 2009-08-31
End: 2010-04-30
Updated: 2010-05-21
Unknown Phase
Asia Pacific and Russia Diagnostic Study for EGFR Testing
Completed
NCT01788163
AstraZeneca
EGFR Mutation Status in aNSCLC Patients
Start: 2013-02-27
End: 2016-06-20
Updated: 2017-05-17
Related Papers
EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study.
2017-09-01
127 citations